Paper23749673
Immunosuppression and HBV reactivation.
Shouval D and 1 other. Semin Liver Dis, 2013. Cited by 137 papers, by iCite.
Cite this record
ConductScience Library. Immunosuppression and HBV reactivation. Papers, record 23749673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23749673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B virus | Major topic |
| Hepatitis B, Chronic | Major topic |
| Immunosuppressive Agents | Major topic |
| Virus Activation | Major topic |
| Animals | |
| Antiviral Agents | |
| Biomarkers | |
| DNA, Viral | |
| Hepatitis B Surface Antigens | |
| Humans | |
| Recurrence | |
| Risk Factors | |
| Treatment Outcome |
Source PubMed
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42444826 | Efficacy and safety of combining TACE with atezolizumab/bevacizumab versus TACE alone: a retrospective propensity score-matched cohort study in HBV-related hepatocellular carcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42444826 | PubMed |
| 42058201 | Total immunoglobulin G concentration as a correlate of anemia in dialysis patients: machine learning analysis of clinical and serological factors. | Front Immunol | 2026 | https://conductscience.org/library/papers/42058201 | PubMed |
| 41443190 | Functional immune responses induced by a capsid assembly modulator in chronic hepatitis B virus-infected humanized mice. | Cell Host Microbe | 2026 | https://conductscience.org/library/papers/41443190 | PubMed |
| 41183666 | Antineoplastic agents-associated hepatitis B virus reactivation: Research progress and molecular mechanisms. | Virus Res | 2025 | https://conductscience.org/library/papers/41183666 | PubMed |
| 41152543 | The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/41152543 | PubMed |
| 41039566 | The immune microenvironment of pathogen-associated cancers and current clinical therapeutics. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41039566 | PubMed |
| 41003568 | Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors. | Trop Med Infect Dis | 2025 | https://conductscience.org/library/papers/41003568 | PubMed |
| 40510114 | HBV reactivation and its management in HBV-related HCC patients undergoing HAIC-TKI-ICI therapy: A multicenter study. | iScience | 2025 | https://conductscience.org/library/papers/40510114 | PubMed |
| 40495049 | Fatal vanishing bile duct syndrome after cord blood transplantation mimicking HBV reactivation. | Clin J Gastroenterol | 2025 | https://conductscience.org/library/papers/40495049 | PubMed |
| 39903324 | Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39903324 | PubMed |
| 39412690 | Hepatitis B surface antigen reverse seroconversion after hematopoietic stem cell transplantation according to the baseline serological marker levels and vaccination status: a single-center database analysis. | Blood Res | 2024 | https://conductscience.org/library/papers/39412690 | PubMed |
| 38482703 | [Comorbidities in multiple sclerosis and their influence on the choice of treatment]. | Rev Neurol | 2024 | https://conductscience.org/library/papers/38482703 | PubMed |
| 38376651 | Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan. | Hepatol Int | 2024 | https://conductscience.org/library/papers/38376651 | PubMed |
| 37731995 | Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37731995 | PubMed |
| 37426446 | The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan. | Front Neurol | 2023 | https://conductscience.org/library/papers/37426446 | PubMed |
| 37326752 | Unusual serological profile in hepatitis B virus (HBV) infection associated with a probable clinical case of acute exacerbation of pre-existing chronic HBV infection. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37326752 | PubMed |
| 36920988 | Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis. | PLoS Med | 2023 | https://conductscience.org/library/papers/36920988 | PubMed |
| 36851587 | Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas. | Viruses | 2023 | https://conductscience.org/library/papers/36851587 | PubMed |
| 36540103 | Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study. | Infect Drug Resist | 2022 | https://conductscience.org/library/papers/36540103 | PubMed |
| 36157140 | Hepatitis B Reactivation Following Eradication of HCV with Direct-Acting Antiviral Drugs (DAAs) in a Cohort of Patients from Different Institutions in Egypt. | J Clin Exp Hepatol | 2022 | https://conductscience.org/library/papers/36157140 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23749673
GET https://conductscience.org/api/papers/v1/23749673/cited_by?page=2